Delivery Order SPE2DB20D1100-SPE2DB24FB6J0
- Not listed
- This federal contract award is for the delivery of Dexmethylphenidate ER 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 31, 2025 with a ceiling value of $1,576.15. The contract is a Firm Fixed Price Delivery Order with a completion date of February 3, 2025. There is no set-aside designation for this...
- This federal contract award is for the delivery of Dexmethylphenidate ER 10 mg capsules, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $1,136.76. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation and has an ultimate completion date of September 18, 2024....
- This federal contract award, valued at $2,033.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of dexmethylphenidate ER 10 mg capsules. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, and the ultimate completion date is June 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The federal contract award is for the delivery of 4567650448 dexmethylphenidate ER 20 mg capsules to the Defense Logistics Agency (DLA). The $2,279.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 20, 2025, with a completion date of March 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.88 firm fixed-price delivery order is for the supply of 4,566,552,109 units of Dexmethylphenidate ER 10 mg capsules. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,514,754 units of the medication Dexmethylphenidate ER 20 mg capsules. The $5,785.27 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery...
- This federal contract award is for the delivery of 4564630290 units of Dexmethylphenidate ER 20 mg capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $1,275.80. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not subject to any set-aside designations. Amerisourcebergen holds a significant...
- The federal contract award summarized is for the delivery of 4,565,943,853 units of Dexmethylphenidate ER 20 mg capsules. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,338.84. The contract is a delivery order with an ultimate completion date of September 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,094.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexmethylphenidate ER 20 mg capsules and has an ultimate completion date of January 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,376,947 units of dexmethylphenidate ER 15 mg capsules, with a total ceiling value of $4,807.44. The contract is a firm fixed-price delivery order, with an ultimate completion date of November 8, 2024. The contract was awarded on November 7, 2024, and there was no set-aside used....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB6J0Delivery Order
This federal contract award is for the delivery of dexmethylphenidate ER 15 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $2,956.00, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, on May 6, 2024. This is a firm fixed-price delivery order contract with a completion date of May 7, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 5/6/24 |